Drug Profile
T 611
Alternative Names: T 0902611; T 902611Latest Information Update: 17 Jun 2002
Price :
$50
*
At a glance
- Originator Tularik
- Class Antivirals; Small molecules
- Mechanism of Action Cytomegalovirus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cytomegalovirus infections
Most Recent Events
- 17 Jun 2002 Discontinued - Phase-II for Cytomegalovirus infections (PO)
- 02 Nov 2001 Phase-II clinical trials for Cytomegalovirus infections (PO)
- 21 Aug 2001 Phase I trials of T 611 have been completed